المؤلفون: Van Der Werff Ten Bosch, Jutte, Kollen, Wj, Ball, Lm, Brinkman, Dm, Vossen, Ac, Lankester, Ac, Egeler, Rm, Bredius, Rg

المساهمون: Pediatrics

مصطلحات موضوعية: integumentary system, lymphohistiocytosis, viruses, varicella zoster, virus diseases, biochemical phenomena, metabolism, and nutrition, hemophagocytic, eye diseases, infection

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______3848::d1115cd56dbf65081f419dc52d7b594d
https://hdl.handle.net/20.500.14017/c00e855e-ccb4-4659-b1b0-4d2c65fd0482

المؤلفون: Versluijs AB; Department of Pediatric Blood and Marrow Transplantation, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Blood and Marrow Transplantation, University Medical Center Utrecht, Utrecht, The Netherlands., de Koning CCH; Laboratory for Translational Immunology, University Medical Center, Utrecht, The Netherlands., Lankester AC; Department of Pediatrics, Willem Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands; and., Nierkens S; Laboratory for Translational Immunology, University Medical Center, Utrecht, The Netherlands., Kollen WJ; Department of Pediatric Blood and Marrow Transplantation, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatrics, Willem Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands; and., Bresters D; Department of Pediatric Blood and Marrow Transplantation, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatrics, Willem Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands; and., Lindemans CA; Department of Pediatric Blood and Marrow Transplantation, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Blood and Marrow Transplantation, University Medical Center Utrecht, Utrecht, The Netherlands., Boelens JJ; Department of Pediatric Blood and Marrow Transplantation, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Blood and Marrow Transplantation, University Medical Center Utrecht, Utrecht, The Netherlands.; Laboratory for Translational Immunology, University Medical Center, Utrecht, The Netherlands.; Stem Cell Transplantation and Cellular Therapy, Memorial Sloan-Kettering, New York, NY., Bierings M; Department of Pediatric Blood and Marrow Transplantation, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Blood and Marrow Transplantation, University Medical Center Utrecht, Utrecht, The Netherlands.

المصدر: Blood advances [Blood Adv] 2022 Mar 22; Vol. 6 (6), pp. 1719-1730.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Graft vs Host Disease*/pathology , Hematopoietic Stem Cell Transplantation* , Leukemia, Myeloid, Acute*/drug therapy, Busulfan/adverse effects ; Child ; Clofarabine ; Humans ; Recurrence ; Vidarabine/analogs & derivatives

المؤلفون: Goemans BF; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. b.f.goemans@prinsesmaximacentrum.nl., Noort S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Pediatric oncology, Sophia Children's hospital, Erasmus medical center, Rotterdam, the Netherlands., Blink M; Department of Pediatrics, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands., Wang YD; Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN, USA., Peters STCJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van Wouwe JP; Department of Child Health, Netherlands Organization of Applied Scientific Research TNO, Leiden, the Netherlands., Kaspers G; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Pediatric Oncology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands.; Dutch Childhood Oncology Group (DCOG), Utrecht, the Netherlands., de Haas V; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Dutch Childhood Oncology Group (DCOG), Utrecht, the Netherlands., Kollen WJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Dutch Childhood Oncology Group (DCOG), Utrecht, the Netherlands., van der Velden VHJ; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands., Gruber TA; Department of Pediatrics, Stanford School of Medicine, Stanford, CA, USA., Zwaan CM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Pediatric oncology, Sophia Children's hospital, Erasmus medical center, Rotterdam, the Netherlands.; Dutch Childhood Oncology Group (DCOG), Utrecht, the Netherlands.

المصدر: Leukemia [Leukemia] 2021 Aug; Vol. 35 (8), pp. 2403-2406. Date of Electronic Publication: 2021 Jan 22.

نوع المنشور: Letter; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Mutation*, Biomarkers, Tumor/*genetics , Down Syndrome/*complications , Early Detection of Cancer/*methods , GATA1 Transcription Factor/*genetics , Leukemia, Myeloid/*diagnosis, DNA Mutational Analysis ; Female ; Follow-Up Studies ; Humans ; Infant, Newborn ; Leukemia, Myeloid/etiology ; Leukemia, Myeloid/pathology ; Male ; Prognosis ; Retrospective Studies

المؤلفون: Sassen SD; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands., Mathôt RA; Department of Hospital Pharmacy, Academic Medical Center, University of Amsterdam, the Netherlands., Pieters R; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Kloos RQ; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands., de Haas V; Dutch Childhood Oncology Group, The Hague, the Netherlands., Kaspers GJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Pediatric Oncology, VU University Medical Center, Amsterdam, the Netherlands., van den Bos C; Department of Pediatric Oncology, Emma Children's Hospital, Academic Medical Center, Amsterdam, the Netherlands., Tissing WJ; Department of Pediatric Oncology, Beatrix Children's Hospital, University Medical Center, Groningen, the Netherlands., Te Loo M; Department of Pediatric Hemato-Oncology, Radboud University Nijmegen Medical Center, the Netherlands., Bierings MB; Pediatric Blood and Marrow Transplantation Program, University Medical Center Utrecht/Wilhelmina Children's Hospital, the Netherlands., Kollen WJ; Department of Pediatric Immunology, Hemato-Oncology and Stem Cell Transplantation, Leiden University Medical Center, the Netherlands., Zwaan CM; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands., van der Sluis IM; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands i.vandersluis@erasmusmc.nl.

المصدر: Haematologica [Haematologica] 2017 Mar; Vol. 102 (3), pp. 552-561. Date of Electronic Publication: 2016 Nov 10.

نوع المنشور: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*administration & dosage , Antineoplastic Agents/*pharmacokinetics , Asparaginase/*administration & dosage , Asparaginase/*pharmacokinetics , Precursor Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy, Administration, Intravenous ; Adolescent ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Male ; Models, Statistical ; Population Surveillance ; Reproducibility of Results

المؤلفون: Van Montfrans JM; Department of Pediatric Immunology and Infectious Diseases, j.vanmontfrans@umcutrecht.nl., Hartman EA; Department of Pediatric Immunology and Infectious Diseases., Braun KP; Department of Child Neurology, Brain Center Rudolf Magnus., Hennekam EA; Department of Medical Genetics, University Medical Center Utrecht, Utrecht., Hak EA; Amsterdam Rheumatology and Immunology Center, Academic Medical Center., Nederkoorn PJ; Department of Neurology, Academic Medical Center, Amsterdam., Westendorp WF; Department of Neurology, Academic Medical Center, Amsterdam., Bredius RG; Department of Pediatrics, Leiden University Medical Center, Leiden., Kollen WJ; Department of Pediatrics, Leiden University Medical Center, Leiden., Schölvinck EH; Department of Pediatric Infectious Diseases, Rheumatology and Immunology, Beatrix Children's Hospital, University Medical Center Groningen, Groningen, The Netherlands., Legger GE; Department of Pediatric Infectious Diseases, Rheumatology and Immunology, Beatrix Children's Hospital, University Medical Center Groningen, Groningen, The Netherlands., Meyts I; Department of Pediatrics, Department of Immunology and Microbiology, University Hospital Leuven, KU Leuven., Liston A; VIB - KU Leuven Department of Microbiology and Immunology, Leuven, Belgium., Lichtenbelt KD; Department of Medical Genetics, University Medical Center Utrecht, Utrecht., Giltay JC; Department of Medical Genetics, University Medical Center Utrecht, Utrecht., Van Haaften G; Department of Medical Genetics, University Medical Center Utrecht, Utrecht., De Vries Simons GM; Department of Medical Genetics, University Medical Center Utrecht, Utrecht., Leavis H; Department of Rheumatology and Clinical Immunology., Sanders CJ; Department of Dermatology, Division of Internal Medicine and Dermatology., Bierings MB; Department of Pediatric Stem Cell Transplantation and., Nierkens S; U-DAIR, Laboratory of Translational Immunology, Department of Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Van Gijn ME; Department of Medical Genetics, University Medical Center Utrecht, Utrecht.

المصدر: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2016 May; Vol. 55 (5), pp. 902-10. Date of Electronic Publication: 2016 Feb 10.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE

مواضيع طبية MeSH: Mutation*, Adenosine Deaminase/*deficiency , Agammaglobulinemia/*genetics , Intercellular Signaling Peptides and Proteins/*deficiency , Severe Combined Immunodeficiency/*genetics, Adenosine Deaminase/blood ; Adenosine Deaminase/genetics ; Agammaglobulinemia/drug therapy ; Child ; Child, Preschool ; Female ; Founder Effect ; Haplotypes ; Homozygote ; Humans ; Immunosuppressive Agents/therapeutic use ; Infant ; Infant, Newborn ; Intercellular Signaling Peptides and Proteins/blood ; Intercellular Signaling Peptides and Proteins/genetics ; Male ; Pedigree ; Phenotype ; Severe Combined Immunodeficiency/drug therapy

SCR Disease Name: Severe combined immunodeficiency due to adenosine deaminase deficiency

المؤلفون: de Rooij JD; Erasmus MC-Sophia Children's Hospital, Pediatric Oncology/Hematology, Rotterdam, The Netherlands., van den Heuvel-Eibrink MM; Erasmus MC-Sophia Children's Hospital, Pediatric Oncology/Hematology, Rotterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Kollen WJ; Pediatric Immunology, Hemato-Oncology and Stem Cell Transplantation, Leiden University Medical Center, Leiden, The Netherlands., Sonneveld E; Dutch Childhood Oncology Group (DCOG), The Hague, the Netherlands., Kaspers GJ; Pediatric Oncology, VU University Medical Center, Amsterdam, The Netherlands., Beverloo HB; Clinical Genetics, Erasmus MC, Rotterdam, The Netherlands.; Dutch Working Group on Hemato-Oncologic Genome Diagnostics, Rotterdam, The Netherlands., Fornerod M; Erasmus MC-Sophia Children's Hospital, Pediatric Oncology/Hematology, Rotterdam, The Netherlands., Pieters R; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Zwaan CM; Erasmus MC-Sophia Children's Hospital, Pediatric Oncology/Hematology, Rotterdam, The Netherlands.

المصدر: Genes, chromosomes & cancer [Genes Chromosomes Cancer] 2016 Mar; Vol. 55 (3), pp. 237-41. Date of Electronic Publication: 2015 Nov 26.

نوع المنشور: Case Reports; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 9007329 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-2264 (Electronic) Linking ISSN: 10452257 NLM ISO Abbreviation: Genes Chromosomes Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Translocation, Genetic*, Carrier Proteins/*genetics , Chromosomal Proteins, Non-Histone/*genetics , Leukemia, Myeloid, Acute/*genetics , Oncogene Proteins, Fusion/*genetics, Amino Acid Sequence ; Base Sequence ; Cell Cycle Proteins ; Cell Differentiation ; Child ; Chromosomes, Human, Pair 11 ; Co-Repressor Proteins ; DNA-Binding Proteins ; Humans ; Male ; Molecular Sequence Data ; Nuclear Pore Complex Proteins/genetics ; Nuclear Pore Complex Proteins/metabolism

المؤلفون: Lugthart G; Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: g.lugthart@lumc.nl., Oomen MA; Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands., Jol-van der Zijde CM; Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands., Ball LM; Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands., Bresters D; Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands., Kollen WJ; Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands., Smiers FJ; Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands., Vermont CL; Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands., Bredius RG; Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands., Schilham MW; Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands., van Tol MJ; Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands., Lankester AC; Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands.

المصدر: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2015 Feb; Vol. 21 (2), pp. 293-9. Date of Electronic Publication: 2014 Oct 16.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Carden Jennings Publishing Country of Publication: United States NLM ID: 9600628 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-6536 (Electronic) Linking ISSN: 10838791 NLM ISO Abbreviation: Biol Blood Marrow Transplant Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation* , Immunocompromised Host*, Adenovirus Infections, Human/*drug therapy , Antiviral Agents/*therapeutic use , Cytosine/*analogs & derivatives , DNA, Viral/*antagonists & inhibitors , Organophosphonates/*therapeutic use , Viremia/*drug therapy, Adenovirus Infections, Human/immunology ; Adenovirus Infections, Human/pathology ; Adenovirus Infections, Human/virology ; Adenoviruses, Human/drug effects ; Adenoviruses, Human/immunology ; Adolescent ; Child ; Child, Preschool ; Cidofovir ; Cohort Studies ; Cytosine/therapeutic use ; DNA, Viral/blood ; Female ; Humans ; Infant ; Killer Cells, Natural/cytology ; Killer Cells, Natural/immunology ; Lymphocyte Count ; Lymphocyte Depletion ; Male ; T-Lymphocytes/cytology ; T-Lymphocytes/immunology ; Transplantation, Homologous ; Viral Load/drug effects ; Viremia/immunology ; Viremia/pathology ; Viremia/virology

المؤلفون: Bresters D; Leiden University Medical Center (LUMC), Willem-Alexander Children's Hospital, Leiden, The Netherlands., Emons JA, Nuri N, Ball LM, Kollen WJ, Hannema SE, Bakker-Steeneveld JD, van der Bom JG, Oostdijk W

المصدر: Pediatric blood & cancer [Pediatr Blood Cancer] 2014 Nov; Vol. 61 (11), pp. 2048-53. Date of Electronic Publication: 2014 Aug 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation/*adverse effects , Primary Ovarian Insufficiency/*etiology , Puberty/*physiology, Adolescent ; Child ; Child, Preschool ; Cohort Studies ; Female ; Humans ; Infant ; Primary Ovarian Insufficiency/epidemiology ; Proportional Hazards Models ; Risk Factors ; Transplantation Conditioning

المؤلفون: Tong WH; Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands;, Pieters R, Kaspers GJ, te Loo DM, Bierings MB, van den Bos C, Kollen WJ, Hop WC, Lanvers-Kaminsky C, Relling MV, Tissing WJ, van der Sluis IM

المصدر: Blood [Blood] 2014 Mar 27; Vol. 123 (13), pp. 2026-33. Date of Electronic Publication: 2014 Jan 21.

نوع المنشور: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Drug Monitoring*, Antineoplastic Agents/*therapeutic use , Asparaginase/*administration & dosage , Asparaginase/*immunology , Erwinia/*enzymology , Polyethylene Glycols/*administration & dosage , Precursor Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy, Adolescent ; Antibodies/blood ; Child ; Child, Preschool ; Escherichia coli Proteins/therapeutic use ; Female ; Humans ; Infant ; Male ; Time Factors ; Treatment Outcome

المؤلفون: te Winkel ML; Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands., Pieters R; Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands; Dutch Childhood Oncology Group, The Hague, The Netherlands., Hop WC; Department of Biostatistics, Erasmus MC - University Medical Center, Rotterdam, The Netherlands., Roos JC; Department of Radiology, VU University Medical Center, Amsterdam, The Netherlands., Bökkerink JP; Dutch Childhood Oncology Group, The Hague, The Netherlands; Department of Pediatric Oncology/Hematology, University Medical Center St Radboud, Nijmegen, The Netherlands., Leeuw JA; Dutch Childhood Oncology Group, The Hague, The Netherlands; Department of Pediatric Oncology, Beatrix Children's Hospital, University of Groningen, Groningen, The Netherlands., Bruin MC; Dutch Childhood Oncology Group, The Hague, The Netherlands; Department of Pediatric Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., Kollen WJ; Dutch Childhood Oncology Group, The Hague, The Netherlands; Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands., Veerman AJ; Dutch Childhood Oncology Group, The Hague, The Netherlands; Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, The Netherlands., de Groot-Kruseman HA; Dutch Childhood Oncology Group, The Hague, The Netherlands., van der Sluis IM; Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands., van den Heuvel-Eibrink MM; Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands; Dutch Childhood Oncology Group, The Hague, The Netherlands. Electronic address: m.vandenheuvel@erasmusmc.nl.

المصدر: Bone [Bone] 2014 Feb; Vol. 59, pp. 223-8. Date of Electronic Publication: 2013 Nov 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: United States NLM ID: 8504048 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2763 (Electronic) Linking ISSN: 18732763 NLM ISO Abbreviation: Bone Subsets: MEDLINE

مواضيع طبية MeSH: Bone Density*, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Fractures, Bone/*epidemiology , Fractures, Bone/*etiology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/*diagnosis , Precursor Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy, Child ; Female ; Humans ; Incidence ; Linear Models ; Lumbar Vertebrae/pathology ; Lumbar Vertebrae/physiopathology ; Male ; Multivariate Analysis ; Netherlands/epidemiology ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications ; Risk Factors